Literature DB >> 11775621

Value of echocardiographic findings in predicting cardiovascular complications in infective endocarditis.

J Mathew1, A Anand, T Addai, S Freels.   

Abstract

Echocardiography allows the detection of vegetations and estimation of valvular dysfunction in patients with infective endocarditis. The value of echocardiographic findings in predicting cardiac and other vascular complications in infective endocarditis is not well understood. Identification of high-risk patients and early surgery may improve their prognosis. The authors reviewed echocardiographic findings and related them to the development of congestive heart failure, systemic embolism, and the need for surgery or the risk of death without surgery in patients with infective endocarditis. There were 125 episodes of endocarditis in 114 patients (84 episodes [67%] in men) with a mean age +/- standard deviation of 37 +/- 7 years. Vegetations were detected by echocardiography on at least 1 valve in 87 episodes (70%); on the mitral valve in 36 episodes (29%); on the aortic valve in 21 episodes (17%); and on the tricuspid valve in 45 episodes (36%). Severe aortic regurgitation was present in 9 episodes (7%) and severe mitral regurgitation in 4 instances (3%). In 12 of 21 episodes (57%) of vegetations on the aortic valve compared with 15 of 104 patients (14%) without vegetations on the aortic valve (p < 0.001), and in 8 of 9 instances (89%) of severe aortic regurgitation compared with 19 of 116 episodes (16%) without severe aortic regurgitation (p<0.00001), the patients developed congestive heart failure. In 18 of 55 episodes (33%) of vegetations on the aortic/mitral valve compared with 17 of 70 episodes (25%) without vegetations on the aortic valve/mitral valve (p = NS), the patients developed systemic embolism. In 13 of 21 episodes (62%) of vegetations on the aortic valve compared with 19 of 104 episodes (19%) without vegetations on the aortic valve (p < 0.001), and in 8 of 9 episodes (89%) of severe aortic regurgitation compared with 24 of 116 episodes (21%) without severe aortic regurgitation (p < 0.00001), the patients either had surgery or died without surgery. Echocardiographic findings do not reliably predict the risk of systemic embolism in patients with infective endocarditis. Vegetations on the aortic valve and severe aortic regurgitation detected by echocardiography predict a high risk of developing congestive heart failure, and for the combined outcome of requiring surgery, or dying without surgery in infective endocarditis. Early surgery may improve the outlook for survival of these patients.

Entities:  

Mesh:

Year:  2001        PMID: 11775621     DOI: 10.1177/000331970105201201

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  4 in total

Review 1.  Possible role of F18-FDG-PET/CT in the diagnosis of endocarditis: preliminary evidence from a review of the literature.

Authors:  Francesco Bertagna; Gianluigi Bisleri; Federica Motta; Giuseppe Merli; Erika Cossalter; Silvia Lucchini; Giorgio Biasiotto; Giovanni Bosio; Arturo Terzi; Claudio Muneretto; Raffaele Giubbini
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-26       Impact factor: 2.357

Review 2.  The potential of FDG PET/CT for early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue.

Authors:  Wengen Chen; Jongho Kim; Olga P Molchanova-Cook; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

Review 3.  Infective endocarditis in congenital heart disease.

Authors:  Walter Knirsch; David Nadal
Journal:  Eur J Pediatr       Date:  2011-07-20       Impact factor: 3.183

4.  Predictors of mortality and adverse events in patients with infective endocarditis: a retrospective real world study in a surgical centre.

Authors:  Valentina Scheggi; Irene Merilli; Rossella Marcucci; Stefano Del Pace; Iacopo Olivotto; Nicola Zoppetti; Nicole Ceschia; Valentina Andrei; Bruno Alterini; Pier Luigi Stefàno; Niccolò Marchionni
Journal:  BMC Cardiovasc Disord       Date:  2021-01-12       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.